Therefore, overexpression of HuR in many cancer types, including oral, colorectal, gastric, lung, breast, ovarian, renal, and melanoma, has been identified and correlated with poor prognosis [23,24,25,26,27,28,29]. Here, ELAVL1 is linked to cancer.